Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04561206
Title Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed Classical Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
University of Chicago Cancer Research Center RECRUITING Chicago Illinois 60637 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Hackensack University Medical Center/John Theurer Cancer Center RECRUITING Hackensack New Jersey 07601 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field